bpc-157 regulatory news Peptides are having a moment. Influencers and “wellness clinic” doctors are selling experimental peptides as the next biohacking frontier — for muscle, recovery, sleep, libido, longevity, you name it. CJC-1295. Ipamorelin. BPC- 157 Regulatory Alert: FDA's April 2026
Description
Traditional treatments often involve medications, physical therapy, or even surgery
The state obesity drug coverage landscape will continue to evolve as states respond to the recent announcement of the BALANCE model (see Box 1) and as states contend with budget challenges and the federal Medicaid spending cuts in the 2025 reconciliation law
FDA Regulatory Framework The FDAs position centers on two realities: (1) BPC-157 is not an approved drug, and (2) FDA has raised safety concerns related to compounding it from bulk substance
It alters glenohumeral kinematics and creates impingement
